Skip to main content

Binding pocket

pharmacology

The cavity in a receptor or other protein that a molecule occupies when it binds, formed by the residues lining it and often sitting at the interface between subunits. Its shape determines which molecules fit and how long they remain, which is why a small structural change to a compound can shift affinity and duration out of proportion to its size.

The binding pocket is the three-dimensional cavity inside a receptor or other protein into which a molecule settles when it attaches. It is shaped by the amino acid residues lining its interior and often sits at the interface between protein subunits. The pocket's geometry, charge distribution, and chemical character together determine what will fit — and how tightly.

A pocket located where the body's own signalling molecules naturally attach is called the orthosteric pocket. Proteins can also carry secondary cavities, known as allosteric sites, positioned elsewhere on the structure. A molecule occupying an allosteric site does not directly block the orthosteric one, but can still alter what the receptor does.

How it works · its role

Binding is not simply a matter of shape. A molecule must match the pocket in three ways simultaneously: its three-dimensional contour, the pattern of electrical charge across its surface, and the distribution of hydrophobic and hydrophilic regions. A good fit allows the molecule and surrounding residues to form multiple weak interactions — hydrogen bonds, van der Waals forces, electrostatic attractions — that together hold the complex in place.

The quality of that fit governs two things: affinity (how readily the molecule binds) and residence time (how long it stays). A ligand that settles deeply into a well-matched pocket can produce a sustained signal even in small amounts. A molecule with almost the right shape may bind briefly and dissociate quickly, yielding a shorter or weaker effect.

The pocket is not rigid. Many receptors shift conformation when a molecule docks — a process called induced fit — which can draw the ligand in more snugly or propagate a structural change through the protein that initiates a downstream signal.

Relevance to substances & effects

Because the binding pocket defines what a receptor responds to, it is the structural basis for drug selectivity. Receptor subtypes — opioid receptors (mu, kappa, delta), or serotonin receptors (5-HT₁A, 5-HT₂A), for example — carry pockets that are similar but not identical. A compound tuned to fit one precisely may have far less affinity for the others, shaping both its intended effect and its side-effect profile.

Pocket geometry also explains why small structural changes can produce large shifts in potency or duration. Adding a single methyl group, flipping a stereochemical centre, or relocating a functional group by one carbon atom can push part of the molecule against a residue it previously cleared — or create a new contact point that holds the ligand in place much longer.

Serotonergic psychedelics, opioids, cannabinoids, and GABAergic depressants each act at distinct receptor families, and the differing shapes of those families' binding pockets is a large part of why they produce such different subjective effects. Pocket similarity also predicts cross-reactivity: when two receptors share a closely matched orthosteric site, a compound active at one is worth examining at the other.

AI-generated · not yet verified by a human reviewer

Harm-reduction reference — not medical advice.

Last updated Aug 24, 2026Report an issue